German Health Insurer Issues First Look at Impact of Medical Cannabis

If anyone (read Auslanders) had any illusions that the German take on medical cannabis was going to be casual or unscientific if not painstakingly documented, think again. Techniker Krankenkasse (or TK as it is referred to by the locals) is one of Germany’s largest public health insurance companies. In other […]

Hazard Analysis and Critical Control Points (HACCP) for the Cannabis Industry: Part 4

In Part 3 of this series on HACCP, Critical Control Points (CCPs), validation of CCPs and monitoring of CCPs were defined. When a HACCP plan identifies the correct CCP, validates the CCP as controlling the hazard and monitors the CCP, a potential hazard is controlled in the manufacturing and packaging […]

Down to a science – why does cannabis alter my brain?

Cannabis Science Depending upon your industry perspective, when I use the term “cannabis science” you may be thinking of optimal plant growth conditions, the latest extraction techniques, or manufacturing technology. Cannabis science is broadly used and has many applications. From my perspective, cannabis science relates to the interactions that take […]

Aurora Expands Canadian (And Global) Footprint

With the summer season (and recreational reform) fast approaching and the continued growth of the European medical market, Canadian LP Aurora has continued to power forward with another corporate acquisition. This time, the firm is medical cannabis firm MedReleaf (TSE:LEAF). The price? $3.2 billion in stock. Aurora shareholders will now […]

Why Traceability Is Crucial for the Cannabis Industry

The stage is set: cannabis legalization is rolling out around the world. With legalization comes regulations and smart companies will adapt to make new requirements work for them. In the end, our shared goal (as industry, consumers and government) is the same: provide safe, high-quality, reliable products. This is where […]

Green Relief Enters European Market Via Switzerland

It is old news that Canadian companies are entering the European market. And it is also no stop-the-presses flash that Germany is a big prize in all of this. But there are other Euro markets to watch right now. Switzerland is one of them. Look for the Canadian influx here […]

Epidiolex Gives GW Pharmaceuticals Boost In Global Markets

GW Pharmaceuticals scored a significant victory in the United States with its cannabis-based epilepsy drug Epidiolex in mid-April. The company received approval from a U.S. Food and Drug Administration (FDA) panel for its use in treating two forms of drug-resistant epilepsy. The drug was granted “orphan drug” status in the […]

A2LA Accredits First Rec Alaska Cannabis Lab

The American Association for Laboratory Accreditation (A2LA) announced recently the accreditation of The New Frontier Research (TNFR) laboratory to ISO/IEC 17025:2005. TNFR, based in Wasilla, Alaska, was previously evaluated by A2LA for competence and proficiency to perform the minimum tests required by Alaska. TFNR is now the first recreational cannabis-testing […]

IoT & Environmental Controls: urban-gro Launches Soleil Technologies Portfolio

Back in November of 2017, urban-gro announced the development of their Soleil Technologies platform, the first technology line for cannabis growers utilizing Internet-of-Things (IoT). Today, urban-gro is announcing that line is now officially available. Screenshot of the data you’d see on the Soleil control panel The technology portfolio, aimed at […]

Refining Techniques for Growing Cannabis

As the cannabis industry in the United States and throughout the world develops, the market is getting more competitive. Markets in a number of states are experiencing disruptions that will have lasting effects for cultivators, including oversupply and supply chain bottlenecks. Now more than ever, growers need to look for […]